Last reviewed · How we verify
NCT05703906: TELEICTUS
Teleneurorehabilitation for the Continuity of Care Post-stroke: a Multicentric Pilot Study
NA trial testing Telerehabilitation - VRRS Khymeia in Stroke in 84 participants. Completed in 31 December 2021.
30 November 2021
Quick facts
| Lead sponsor | IRCCS San Camillo, Venezia, Italy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 84 |
| Start date | 16 March 2018 |
| Primary completion | 30 November 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Telerehabilitation - VRRS Khymeia
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
IRCCS San Camillo, Venezia, Italy
Who can join
Adults 18 to 80, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main aim of this longitudinal, pilot study is to evaluate the feasibility of a multi-domain (i.e., motor, language and cognitive domains) telerehabilitation system using the Virtual Reality Rehabilitation System (VRRS, Khymeia) in patients with stroke. Furthermore, data on patients' needs and clinical data will be collected before and after treatment and then analyzed.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The role of virtual reality-based cognitive training in enhancing motivation and cognitive functions in individuals with chronic stroke.
Maggio MG, Bonanno L, Rizzo A, Barbera M, et al · · 2025 · cited 4× · PMID 40652006 · DOI 10.1038/s41598-025-08173-1 -
Telerehabilitation for Stroke: A Personalized Multi-Domain Approach in a Pilot Study.
Federico S, Cacciante L, De Icco R, Gatti R, et al · · 2023 · cited 4× · PMID 38138919 · DOI 10.3390/jpm13121692 -
Feasibility, acceptability, usability and quality of life levels in post-stroke patients undergoing telerehabilitation: Results from a multicentric pilot study.
Cacciante L, Federico S, Maistrello L, Kiper P, et al · · 2025 · cited 2× · PMID 39944115 · DOI 10.1177/20552076241308617
Verify or expand the search:
- PubMed search for NCT05703906
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other IRCCS San Camillo, Venezia, Italy trials
Trials by the same sponsor.
- NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
- NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
- NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
- NCT06270420 — Technological Devices and Home Automation System in Neurological Rehabilitation · NA · unknown
- NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05703906 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
- Last refreshed: 30 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05703906.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing